381 related articles for article (PubMed ID: 26990051)
1. Anti-inflammatory agents in the treatment of bipolar depression: a systematic review and meta-analysis.
Rosenblat JD; Kakar R; Berk M; Kessing LV; Vinberg M; Baune BT; Mansur RB; Brietzke E; Goldstein BI; McIntyre RS
Bipolar Disord; 2016 Mar; 18(2):89-101. PubMed ID: 26990051
[TBL] [Abstract][Full Text] [Related]
2. Anti-inflammatory treatments for mood disorders: Systematic review and meta-analysis.
Husain MI; Strawbridge R; Stokes PR; Young AH
J Psychopharmacol; 2017 Sep; 31(9):1137-1148. PubMed ID: 28858537
[TBL] [Abstract][Full Text] [Related]
3. Targeting the immune system in the treatment of bipolar disorder.
Rosenblat JD
Psychopharmacology (Berl); 2019 Oct; 236(10):2909-2921. PubMed ID: 30756134
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and tolerability of minocycline for depression: A systematic review and meta-analysis of clinical trials.
Rosenblat JD; McIntyre RS
J Affect Disord; 2018 Feb; 227():219-225. PubMed ID: 29102836
[TBL] [Abstract][Full Text] [Related]
5. A Double-Blind, Randomized, Placebo-Controlled Study of Aspirin and N-Acetylcysteine as Adjunctive Treatments for Bipolar Depression.
Bauer IE; Green C; Colpo GD; Teixeira AL; Selvaraj S; Durkin K; Zunta-Soares GB; Soares JC
J Clin Psychiatry; 2018 Dec; 80(1):. PubMed ID: 30549489
[TBL] [Abstract][Full Text] [Related]
6. Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials.
Köhler O; Benros ME; Nordentoft M; Farkouh ME; Iyengar RL; Mors O; Krogh J
JAMA Psychiatry; 2014 Dec; 71(12):1381-91. PubMed ID: 25322082
[TBL] [Abstract][Full Text] [Related]
7. Taking the fuel out of the fire: evidence for the use of anti-inflammatory agents in the treatment of bipolar disorders.
Ayorech Z; Tracy DK; Baumeister D; Giaroli G
J Affect Disord; 2015 Mar; 174():467-78. PubMed ID: 25553408
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial modulators in the treatment of bipolar depression: a systematic review and meta-analysis.
Liang L; Chen J; Xiao L; Wang Q; Wang G
Transl Psychiatry; 2022 Jan; 12(1):4. PubMed ID: 35013098
[TBL] [Abstract][Full Text] [Related]
9. N-acetylcysteine for major mental disorders: a systematic review and meta-analysis of randomized controlled trials.
Zheng W; Zhang QE; Cai DB; Yang XH; Qiu Y; Ungvari GS; Ng CH; Berk M; Ning YP; Xiang YT
Acta Psychiatr Scand; 2018 May; 137(5):391-400. PubMed ID: 29457216
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of adjunctive second-generation antidepressant therapy with a mood stabiliser or an atypical antipsychotic in acute bipolar depression: a systematic review and meta-analysis of randomised placebo-controlled trials.
McGirr A; Vöhringer PA; Ghaemi SN; Lam RW; Yatham LN
Lancet Psychiatry; 2016 Dec; 3(12):1138-1146. PubMed ID: 28100425
[TBL] [Abstract][Full Text] [Related]
11. Omega-3 for bipolar disorder: meta-analyses of use in mania and bipolar depression.
Sarris J; Mischoulon D; Schweitzer I
J Clin Psychiatry; 2012 Jan; 73(1):81-6. PubMed ID: 21903025
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of long-term antidepressant treatment for bipolar disorders - A meta-analysis of randomized controlled trials.
Liu B; Zhang Y; Fang H; Liu J; Liu T; Li L
J Affect Disord; 2017 Dec; 223():41-48. PubMed ID: 28715727
[TBL] [Abstract][Full Text] [Related]
13. Comparative efficacy, acceptability, and tolerability of adjunctive anti-inflammatory agents on bipolar disorder: A systemic review and network meta-analysis.
Xu H; Du Y; Wang Q; Chen L; Huang J; Liu Y; Zhou C; Du B
Asian J Psychiatr; 2023 Feb; 80():103394. PubMed ID: 36525766
[TBL] [Abstract][Full Text] [Related]
14. The effect of N-acetylcysteine on bipolar depression: a systematic review and meta-analysis of randomized controlled trials.
Pittas S; Theodoridis X; Haidich AB; Bozikas PV; Papazisis G
Psychopharmacology (Berl); 2021 Jul; 238(7):1729-1736. PubMed ID: 33641060
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of anti-inflammatory agents for the treatment of major depressive disorder: a systematic review and meta-analysis of randomised controlled trials.
Bai S; Guo W; Feng Y; Deng H; Li G; Nie H; Guo G; Yu H; Ma Y; Wang J; Chen S; Jing J; Yang J; Tang Y; Tang Z
J Neurol Neurosurg Psychiatry; 2020 Jan; 91(1):21-32. PubMed ID: 31658959
[TBL] [Abstract][Full Text] [Related]
16. Pharmacologic implications of inflammatory comorbidity in bipolar disorder.
Rosenblat JD; Gregory JM; McIntyre RS
Curr Opin Pharmacol; 2016 Aug; 29():63-9. PubMed ID: 27400335
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of anti-inflammatory treatment interventions on depression in individuals with major depressive disorder and high levels of inflammation: A systematic review of randomized clinical trials.
Allison DJ; Sharma B; Timmons BW
Physiol Behav; 2019 Aug; 207():104-112. PubMed ID: 31078670
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness and tolerance of anti-inflammatory drugs' add-on therapy in major mental disorders: a systematic qualitative review.
Fond G; Hamdani N; Kapczinski F; Boukouaci W; Drancourt N; Dargel A; Oliveira J; Le Guen E; Marlinge E; Tamouza R; Leboyer M
Acta Psychiatr Scand; 2014 Mar; 129(3):163-79. PubMed ID: 24215721
[TBL] [Abstract][Full Text] [Related]
19. Antidepressants for the acute treatment of bipolar depression: a systematic review and meta-analysis.
Sidor MM; Macqueen GM
J Clin Psychiatry; 2011 Feb; 72(2):156-67. PubMed ID: 21034686
[TBL] [Abstract][Full Text] [Related]
20. Adjunctive minocycline for major mental disorders: A systematic review.
Zheng W; Zhu XM; Zhang QE; Cheng G; Cai DB; He J; Ng CH; Ungvari GS; Peng XJ; Ning YP; Xiang YT
J Psychopharmacol; 2019 Oct; 33(10):1215-1226. PubMed ID: 31294649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
